case report: combination therapy with mesenchymal stem cells and granulocyte-colony stimulating factor in a case of spinal cord injury
Clicks: 148
ID: 217328
2015
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
148 views
26 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #26 of 29 articles by views in gastrointestinal cancer: targets and therapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Introduction: Various neuroregenerative procedures have been recently employed along with
neurorehabilitation programs to promote neurological function after Spinal Cord Injury (SCI),
and recently most of them have focused on the acute stage of spinal cord injury. In this report,
we present a case of acute SCI treated with neuroprotective treatments in conjunction with
conventional rehabilitation program.
Methods: A case of acute penetrative SCI (gunshot wound), 40 years old, was treated with
intrathecal bone marrow derived stem cells and parenteral Granulocyte-Colony Stimulating
Factor (G-CSF) along with rehabilitation program. The neurological outcomes as well as safety
issues have been reported. Results: Assessment with American Spinal Injury Association (ASIA), showed neurological
improvement, meanwhile he reported neuropathic pain, which was amenable to oral medication. Discussion: In the acute setting, combination therapy of G-CSF and intrathecal Mesenchymal
Stem Cells (MSCs) was safe in our case as an adjunct to conventional rehabilitation programs.
Further controlled studies are needed to find possible side effects, and establish net efficacy.
| Reference Key |
derakhshanrad2015basiccase
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Nazi Derakhshanrad;Hooshang Saberi;Keyvan Tayebi Meybodi;Mohammad Taghvaei;Babak Arjmand;Hamid Reza Aghayan;Amir Hassan Kohan;Mohammad Haghpanahi;Shahrokh Rahmani |
| Journal | gastrointestinal cancer: targets and therapy |
| Year | 2015 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.